Agile Therapeutics, Inc. to appoint Jason Butch, the company's Vice President and Chief Accounting Officer, to serve as Principal Financial Officer, in addition to his current role as Principal Accounting Officer.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.384 USD | -2.29% | +1.19% | -80.31% |
05-15 | Earnings Flash (AGRX) AGILE THERAPEUTICS Posts Q1 Revenue $5.7M | MT |
03-28 | Transcript : Agile Therapeutics, Inc., Q4 2023 Earnings Call, Mar 28, 2024 |
1st Jan change | Capi. | |
---|---|---|
-80.31% | 2.63M | |
+11.16% | 115B | |
+12.85% | 106B | |
-4.13% | 24.69B | |
-2.33% | 21.97B | |
-6.03% | 19.27B | |
-11.79% | 17.56B | |
-40.50% | 17.32B | |
+7.58% | 14.03B | |
+32.89% | 12.13B |
- Stock Market
- Equities
- AGRX Stock
- News Agile Therapeutics, Inc.
- Agile Therapeutics, Inc. to Appoint Jason Butch as Principal Financial Officer